FLT PET/CT
FLT PET/CT is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 33.3%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
25.0%
1 of 4 finished
75.0%
3 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy
Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients
Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
Clinical Trials (6)
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy
Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients
Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
Early Response Assessment of Induction Chemotherapy in Acute Myeloid Leukemia Patients Using F-18 FLT PET/CT
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6